Al Gray
Business Development Director
clinical research
euroscreen
Netherlands
Biography
Al Gray has been responsible for business development at Euroscreen since 1999. His previous positions were at Abbott Laboratories where he served for 22 years in pharmaceutical and diagnostic research and development, strategic planning and partnering, and as the founder of Recombinant Capital Europe AG, in Basel from 1998 to 2001. He received his Ph.D. in biochemistry from Northwestern University. Postdoctoral years were spent at Brandeis University and the University of Illinois Medical Center, specializing in immunology and protein biochemistry.
Research Interest
Clinical and Laboratory Research